## **Core Concept**
Kostmann syndrome, also known as severe congenital neutropenia, is a rare, inherited disorder characterized by a significant reduction in the number of neutrophils, a type of white blood cell crucial for fighting infections. This condition leads to recurrent severe infections. The underlying issue is often related to genetic mutations affecting **neutrophil production** or function.

## **Why the Correct Answer is Right**
The correct treatment for Kostmann syndrome involves **recombinant human granulocyte-colony stimulating factor (rhG-CSF)**, which stimulates the bone marrow to produce more neutrophils. This therapy directly addresses the root cause of the condition by promoting the production of **neutrophils**, thereby enhancing the body's ability to fight infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, although antibiotics may be used to treat infections in patients with Kostmann syndrome, they do not address the underlying cause of the condition, which is the lack of neutrophils.
- **Option B:** This option is incorrect as it does not directly relate to the treatment of Kostmann syndrome. While bone marrow transplantation (hematopoietic stem cell transplantation) can be curative for some types of neutropenia or bone marrow failure syndromes, it is not the first-line treatment for Kostmann syndrome.
- **Option C:** This option might seem plausible as it could relate to various treatments, but without specifics, it's hard to directly refute. However, given that rhG-CSF is a targeted therapy for increasing neutrophil counts, any option not directly related to increasing neutrophil production or addressing the specific deficiency would be incorrect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients with Kostmann syndrome are at a high risk of recurrent infections, particularly those caused by **common pathogens** such as *Staphylococcus aureus*, *Pseudomonas aeruginosa*, and *Escherichia coli*. Early diagnosis and treatment with **rhG-CSF** can significantly improve outcomes by reducing the frequency and severity of infections.

## **Correct Answer:** .